Robert Schleimer

Professor of Allergy & Immunology, Department of Medicine at Northwestern University - Feinberg School of Medicine

Robert Schleimer

Robert Schleimer

Professor of Allergy & Immunology, Department of Medicine at Northwestern University - Feinberg School of Medicine

Biography

Robert P. Schleimer, Ph.D.

Robert P. Schleimer majored in Biology at The University of California, San Diego and received a Ph.D. in pharmacology and toxicology at UC Davis. He received post-doctoral fellowship training at the Johns Hopkins University School of Medicine in the Division of Clinical Immunology. Dr. Schleimer joined the faculty at Johns Hopkins and rose through the ranks to become Professor of Medicine.

Dr. Schleimer moved to Chicago to become the Roy and Elaine Patterson Chair and Chief of the Division of Allergy-Immunology at Northwestern University Feinberg School of Medicine in 2004. Dr. Schleimer has published over 260 papers and edited numerous books and journal supplements. Dr. Schleimer has trained over 35 post-doctoral fellows and graduate students during his research career, most of whom have gone on to become established investigators in academia and industry. Dr. Schleimer was recognized as one of the most highly cited researchers of the last two decades worldwide by The Institute for Scientific Information (ISI). Dr. Schleimer has served on numerous journal review boards and committees at the National Institutes of Health and has recently been Chair of the Lung Cell and Molecular Immunology Study Section and the Severe Asthma Research Program Study Section.

Dr. Schleimer's laboratory has received continuous NIH funding for over 25 years and he is a recent recipient of a prestigious NIH MERIT award from the National Heart Lung and Blood Institute. Dr. Schleimer has been on the Scientific Advisory Boards of over a dozen pharmaceutical companies, including big pharma and start-ups. He has also been on advisory boards for the NIH, Johns Hopkins, Duke, University of Wisconsin and numerous professional societies. He is presently actively involved in studying the cellular and molecular mechanisms of allergic disease.

Overview
RelSci Relationships

56

Number of Boards

4

Relationships
RelSci Relationships are individuals Robert Schleimer likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Exicure Operating Co.

Relationship likelihood: Strong

Hematologist-Oncologist, Provost & Chief Scientific Officer, Irell & Manella Cancer Center Director's Distinguished Chair, Morgan & Helen Chu Director's Chair of the Beckman Research Institute Director at City of Hope - California

Relationship likelihood: Strong

Member, Scientific Advisory Board at Scioderm, Inc.

Relationship likelihood: Strong

Senior Vice President & Chief Commercial Officer at Assertio Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Tyree & D'Angelo Partners LLC

Relationship likelihood: Strong

Science & Technology Advisory Council at Government of the United States of America

Relationship likelihood: Strong

Co-Founder at BioMarck Pharmaceuticals Ltd.

Relationship likelihood: Strong

Deputy President at Nanyang Technological University

Relationship likelihood: Strong

Chief Medical Officer at Amplyx Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Financial Officer at Exicure Operating Co.

Relationship likelihood: Strong

Paths to Robert Schleimer
Potential Connections via
Relationship Science
You
Robert Schleimer
Professor of Allergy & Immunology, Department of Medicine at Northwestern University - Feinberg School of Medicine
Career History
Professor of Allergy & Immunology, Department of Medicine
Current

Northwestern University Feinberg School of Medicine, founded in 1859, attracts talented individuals to its faculty, staff, and student body through its cutting-edge research initiatives, superb clinical affiliates, global outlook, and innovative curriculum. Located in the heart of Chicago’s Magnificent Mile, Feinberg has built a national reputation for excellence through a strong history of collaborative, interdisciplinary medical education and research, and along with Northwestern Memorial Hospital and Northwestern Medical Faculty Foundation is part of the premier academic medical center known as Northwestern Medicine. Feinberg stands out among the nation's research-intensive medical schools and consistently receives high marks in U.S. News & World Report surveys. Through its affiliates, it provides patient care to thousands of individuals every year, and plays an integral part in the communities it serves.

Boards & Committees
Member, Scientific Advisory Board
Current

BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC.

Member, Scientific Advisory Board
Current

Allakos, Inc. engages in the development of therapeutic antibodies. Its primary product is AK002, a monoclonal antibody used for the treatment of various eosinophil and mast cell related diseases such as eosinophilic gastritis, urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis. The company was founded by Christopher Bebbington, Nenad Tomasevic, Bruce S. Bochner, and Robert Schleimer in 2012 and is headquartered in Redwood, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Robert Schleimer. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Robert Schleimer's profile does not indicate a business or promotional relationship of any kind between RelSci and Robert Schleimer.